ARTICLE | Clinical News

Tenofovir alafenamide fumarate regulatory update

November 24, 2014 8:00 AM UTC

Gilead submitted an NDA to FDA for a single, once-daily tablet containing Tenofovir alafenamide fumarate, elvitegravir, cobicistat and emtricitabine to treat HIV infection in adults. The company plans to submit an MAA in the EU by year end for the product. ...